Calibrate
Clinician-guided metabolic health program structured as a 1-year commitment with GLP-1 prescribing, labs, 1:1 coaching, app-based tracking, and behavior change. The clinical protocol goes beyond GLP-1 prescribing alone but centers on medication-supported metabolic improvement rather than a nutrition-only or surgery-based model. Prescribes FDA-approved GLP-1s including Wegovy and Zepbound, plus oral GLP-1 options. Sells to consumers and employers.
Access model
D2C and employer-sponsored programs
Editorial note
One of the most outcomes-forward GLP-1 + lifestyle models, but heavier reliance on insurance navigation for medication affordability.
Coverage and cost
Program fee is separate, but Calibrate says it helps members access low-cost covered GLP-1s, often around $25/mo or less after deductible if eligible
$199/mo with an initial 3-month commitment. Cancel anytime after the initial 3-month period.
No; public materials focus on FDA-approved GLP-1s and oral GLP-1 options
Market signals
Evidence and positioning
Strong public outcomes story. 2025 results report cites 15.7% average weight loss at 12 months, 17.2% at 24 months, and 19.1% at 36 months; employer-sponsored analysis cites 17.8% at 12 months.
This is the lower dB's current read on Calibrate's pricing posture, insurance story, medication posture, and evidence signaling.
Source References
6 public references used in this profile. Links open in a new tab for quick verification.
Pricing, insurance coverage, medication availability, and eligibility can change quickly. Verify current details directly with the provider before starting or switching care.